Skip to main content
Premium Trial:

Request an Annual Quote

MDS Renews Shareholders Rights Plan

NEW YORK (GenomeWeb News) – MDS said that its shareholders have approved the renewal of the firm's shareholders rights plan.

The Toronto-based firm said shareholders approved the renewal last week at its annual and special meeting of shareholders. The latest plan, which is intended to discourage a hostile takeover bid, will expire in 2012 unless it is renewed.

MDS said that the primary purpose of the plan is to encourage any party that becomes owner of 20 percent or more of its common shares to either make a permitted bid or to negotiate the terms of an offer with the board of directors. If a party does become a 20 percent or greater stakeholder in the firm outside of making a permitted bid or negotiating with the board, shareholders would be entitled to purchase additional common shares from MDS at a 50 percent discount to market, which would dilute the offeror's position, said MDS.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.